NATCO PHARMA LIMITED (INDIA)
Lapatinib-herduo
“Lapatinib” is the Drug / Molecule content in "Herduo". Herduo belongs to a class of medications called tyrosine kinase inhibitor. Tyrosine kinase is protein on the surface of a cell which sends the signals. Lapatinib blocks the signals from the tyrosine kinase. Blocking the signals they stop the growth of those cancer cells in body.
Indication
Herduo has used together with another medicine called capecitabine or letrozole to treat a certain type of advanced or metastatic breast cancer that has spread to other parts of the body.
Note
Precaution
- Herduo is a prescription drug and should be used under proper medical guidance and advice.
- Herduo may cause a condition that affect the heart rhythm.
- Herduo is not recommended for use during pregnancy. It may harm an unborn baby. Therefore, it is important to prevent pregnancy while taking this medication.
- Herduo may cause Liver Damage
Updated On Oct 26, 2019 by Admin
Strength
250 mg
Packing
1 x 150 Tablets (Bottle) & 1 X 30 Tablets (Bottle)
Storage
Store between 15°C to 30°C.